Latest News
HaemAnalytica win at the Thames Valley Innovation and Tech Awards 2026
Today
HaemAnalytica won two awards at the Thames Valley Innovation and Tech Awards 2026 — Innovative Tech of the Year and Tech Start-up of the Year — recognised for cutting-edge research underpinning scalable medical technology with measurable patient outcomes.
International Day of Women and Girls in Science: Inspiring the next generation
7 days ago
For International Day of Women and Girls in Science, we joined the ARC Mindset event in Manchester, inspiring girls aged 14-16 into STEM. Our COO, Gemma Little, spent the day discussing platelets and blood clotting with students — with a little help from our resident "Platelet Pal".
HaemAnalytica at BioNow Precision Medicine
7 days ago
Bill and Gemma exhibited at Precision Medicine, enjoying sessions on personalised treatment approaches. TRIPLEcheck was designed to identify individuals at risk of heart attacks and strokes, and it was great to hear other exciting developments.
HaemAnalytica at BioTrinity 2026
7 days ago
Chris, Jon, Bill and Jeremy attended BioTrinity 2026, with Chris presenting in the seed stage R&D session hosted by Syneos. It was a fantastic few days, and the team is already looking forward to next year's event.
HaemAnalytica receives £300,000 investment from the University of Reading
7 days ago
HaemAnalytica has received a £300,000 investment from the University of Reading, where the company was spun out by Prof. Jon Gibbins and Assoc. Prof. Chris Jones. Led by CEO William Kilgallon, COO Gemma Little and CFO Jeremy Rowson, HaemAnalytica is set to revolutionise precision medicine through novel platelet assays.
A new advent of clinical pathway management: an article in PME
7 days ago
Our first PME article explores how measuring platelet function could transform drug discovery, development and clinical trials. PLANA, our platelet function assay, helps select high-efficacy drug assets and de-risk clinical trials through better patient stratification.
Optimising therapy to improve outcomes for heart attack and stroke patients
7 days ago
Our second PME article explores how TRIPLEcheck can personalise treatment for heart attack and stroke patients. Rather than a "one size fits all" approach, testing platelet activity allows patient stratification to optimise treatment, reducing recurrent events and improving outcomes.
HaemAnalytica at London Labs Live
7 days ago
Gemma and Jon recently exhibited at London Labs Live in the start-up zone – a great opportunity to meet other start-ups and see the future of labs in person.
Latest events
